These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 2161377)

  • 1. CRF, urotensin I, and sauvagine stimulate the release of POMC-derived peptides from goldfish neurointermediate lobe cells.
    Tran TN; Fryer JN; Lederis K; Vaudry H
    Gen Comp Endocrinol; 1990 Jun; 78(3):351-60. PubMed ID: 2161377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRH stimulates the release of POMC-derived peptides from goldfish melanotropes.
    Tran TN; Fryer JN; Bennett HP; Tonon MC; Vaudry H
    Peptides; 1989; 10(4):835-41. PubMed ID: 2555798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urotensin I, a CRF-like neuropeptide, stimulates acth release from the teleost pituitary.
    Fryer J; Lederis K; Rivier J
    Endocrinology; 1983 Dec; 113(6):2308-10. PubMed ID: 6315348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides.
    Verburg-Van Kemenade BM; Jenks BG; Cruijsen PM; Dings A; Tonon MC; Vaudry H
    Peptides; 1987; 8(6):1093-100. PubMed ID: 2831518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cortisol inhibits the ACTH-releasing activity of urotensin I, CRF and sauvagine observed with superfused goldfish pituitary cells.
    Fryer J; Lederis K; Rivier J
    Peptides; 1984; 5(5):925-30. PubMed ID: 6095221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of corticotropin-releasing factor, arginine vasopressin, and related neuropeptides on the secretion of ACTH and alpha-MSH by frog anterior pituitary cells and neurointermediate lobes in vitro.
    Tonon MC; Cuet P; Lamacz M; Jégou S; Côté J; Gouteaux L; Ling N; Pelletier G; Vaudry H
    Gen Comp Endocrinol; 1986 Mar; 61(3):438-45. PubMed ID: 3007273
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of CRF- and urotensin I-stimulated ACTH release from goldfish pituitary cell columns by the CRF analogue alpha-helical CRF-(9-41).
    Weld MM; Fryer JN; Rivier J; Lederis K
    Regul Pept; 1987 Dec; 19(5-6):273-80. PubMed ID: 2830643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The fish neuropeptide urotensin I: its physiology and pharmacology.
    Lederis K; Fryer JN; Yulis CR
    Peptides; 1985; 6 Suppl 3():353-61. PubMed ID: 3008124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II stimulation of teleost adrenocorticotropic hormone release: interactions with urotensin I and corticotropin-releasing factor.
    Weld MM; Fryer JN
    Gen Comp Endocrinol; 1988 Mar; 69(3):335-40. PubMed ID: 2834258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS; Lu CL; Seidah NG; Chretien M
    Endocrinology; 1982 Oct; 111(4):1388-90. PubMed ID: 6288359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Processing, turnover and release of corticotropins, endorphins and melanotropin in the toad pituitary intermediate lobe.
    Loh YP
    Ciba Found Symp; 1981; 81():55-78. PubMed ID: 6268383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of ovine corticotropin-releasing hormone and FK 33-824 (met-enkephalin analogue) on the secretions of proopiomelanocortin-derived N-terminal peptide, beta-lipotropin, beta-endorphin and adrenocorticotropin in patients with Addison's disease.
    Sekiya K; Nawata H; Kato K; Motomatsu T; Ibayashi H
    Endocrinol Jpn; 1986 Dec; 33(6):761-8. PubMed ID: 3034555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACTH-releasing activity of urotensin I and ovine CRF: interactions with arginine vasotocin, isotocin and arginine vasopressin.
    Fryer J; Lederis K; Rivier J
    Regul Pept; 1985 May; 11(1):11-5. PubMed ID: 2989979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. beta-Adrenergic stimulation of the release of ACTH- and LPH-related peptides from the pars intermedia of the rat pituitary gland.
    Tilders FJ; Post M; Jackson S; Lowry PJ; Smelik PG
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):343-51. PubMed ID: 6114609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of synthetic corticotropin-releasing factor and dopamine on the release of immunoreactive beta-endorphin/beta-lipotropin and alpha-melanocyte-stimulating hormone from human fetal pituitaries in vitro.
    Gibbs DM; Stewart RD; Liu JH; Vale W; Rivier J; Yen SS
    J Clin Endocrinol Metab; 1982 Dec; 55(6):1149-52. PubMed ID: 6290522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytochemical localization of pro gamma MSH, gamma MSH, ACTH and beta endorphin/beta lipotrophin in the fetal sheep pituitary: an ontogenetic study.
    Mulvogue HM; McMillen IC; Robinson PM; Perry RA
    J Dev Physiol; 1986 Oct; 8(5):355-68. PubMed ID: 3025283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo ACTH-releasing activity of ovine CRF, sauvagine and urotensin I.
    Rivier C; Rivier J; Lederis K; Vale W
    Regul Pept; 1983 Jan; 5(2):139-43. PubMed ID: 6298906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential acetylation of pro-opiomelanocortin-derived peptides in the pituitary gland of Xenopus laevis in relation to background adaptation.
    van Strien FJ; Galas L; Jenks BG; Roubos EW
    J Endocrinol; 1995 Jul; 146(1):159-67. PubMed ID: 7561613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-translational processing of pro-opiomelanocortin (POMC)-derived peptides during fetal monkey pituitary development. II. beta-Lipotropin (beta-LPH)-related peptides.
    Hatfield JM; Allen RG; Stack J; Ronnekleiv O
    Dev Biol; 1988 Mar; 126(1):164-72. PubMed ID: 2963776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.